Skinbiotherapeutics Share Discussion Threads

[trotterstrading] 08/4/2019 16:03

Lll, rest assured further testing will be done with a commercial partner!

[lord loads of lolly] 08/4/2019 15:43

As an indirect holder (via Opti), I've an interest in SBTX doing well. And I think it stands a very good chance in the medium term. But IMHO there's a lot of confirmation bias on this BB today. My 31 March posts suggested Cath's pre-results comments implied the trial wouldn't be 100% conclusive. My take on things was dismissed by some at the time. But for all the spin on here today, that's exactly where we're at now. I'm not saying today's RNS was bad, just that it wasn't 100% conclusive. So there's an element of uncertainty still, in terms of formulation tweaks that might well do the trick but can't be seen as a foregone conclusion. Today's share price (down just > 8% at the time of writing), is - I think - a more reliable indicator than some on here would have you believe.

[shrewdmole] 08/4/2019 14:09

Risky

It’s scary how little some people understand about the company they are invested in.

Cath is very pleased.
Soh is very pleased.

We sell the science and the product formulation will be done by partners.

This is now prime with the trial results and the newly appointed ceo for the commercial deals to start being announced. I suspect the bones of a deal and terms have been agreed subject to the trial data.

I’ve added substantially on the back of today’s rns.

S

[slartybartfaster] 08/4/2019 11:23

Elrico pulls no punches.https://lemminginvestors.blogspot.com/?m=1

[pretax2] 08/4/2019 10:18

Just add w w w at the front

proactiveinvestors.co.uk/companies/news/218112/skinbiotherapeutics-chief--really-pleased--with-human-trial-data-for-new-skin-cream-218112.html

[riskybusiness1] 08/4/2019 09:49

Very important from SOH'Investors have to remember they were testing SkinBiotix in moisturising cream against cream alone on normal skin to see if their was any effect.'This is actually really good news. Definitely see commercial discussions fruit from this with Stuart Ashman.

[rafboy] 08/4/2019 09:39

Thanks Primal, if SOH is happy so am I.

[trotterstrading] 08/4/2019 09:35

Yes I think a blue finish is on the cards. The ONLY thing that matters is commercial partners see value and strike deals.. speaking with Cath at UKI it seems they are VERY pleased and it sounded to me like they were itching to strike commercial deals. Cath knows what she is taking about remember she deals with the mega Corporates ALL THE TIME, they reach out to her lab as a global leader in skin health. A deal(s) are nailed on IMHO

[primal123] 08/4/2019 09:34

SOH: "I am happy with the results and believe they will make a real difference in commercial discussions. Investors have to remember they were testing SkinBiotix in moisturising cream against cream alone on normal skin to see if their was any effect. They weren't testing for a disease state e.g cholesterol and so any effect is really significant. I know the scientists are excited over this result. I think the difficulty SBTX have is communicating a complex message to retail investors in an RNS, which by its nature is very regulatory and allows no context."

[anderson3] 08/4/2019 09:31

Cath certainly knows how to deliver an RNS . Not!!

[7ilas] 08/4/2019 09:26

This will finish Blue today.

[riskybusiness1] 08/4/2019 09:23

Could go blue after realisation sets in.

[riskybusiness1] 08/4/2019 09:21

Those trades from earlier are why we got taken down. Someone panicking thinking it's bad news. They must annoyed watching it recover

[jamesrs1] 08/4/2019 09:13

Pretax2. Fair dos. For once I agree with you.

[riskybusiness1] 08/4/2019 09:08

It's as good a result there could be on healthy skin. Could have set the scene better which wouldn't have caused early drop

[rafboy] 08/4/2019 09:05

Think there may be some who regret selling today.

[pretax2] 08/4/2019 08:59

This is a treeshake
5 bagging hero’s exit stage left, investors top.
Investors will win the day eventually.

[trotterstrading] 08/4/2019 08:53

Indeed. We now have PROVEN EFFICACY remember it's the technology that will be out licensed NOT THE FORMULATION. That can be tweaked to suit the corporate. One hell of a bounce coming when the market catches on

[owenmo] 08/4/2019 08:52

Sure didn't Cath give us a shortened version of to-day's news a week or so ago. Of course many of us are disappointed - waiting months for this breakthrough moment. A doubling of share price was suggested by some, with good reason. Now it's back to wait-and-see routine. One's hopes are sustained by (a) not negative results (b) recent £1.5m equity take-up and (c) high-grade CEO coming on board. Patience !!!!

[pretax2] 08/4/2019 08:49

Good results imo. Will buy more when dust settles.

You can only hydrate something so much before saturation. With skin it takes 29 days apparently. But don’t stop using the cream or your skin will get progressively drier. Remember that the skin cream is applying an effect on top of an effect which, in this case is provided by the skin itself. In such cases and using a sample of healthy adults, it’s difficult to get a significant result. The fact this has happened is great news.

Some tinkering with dose would be helpful to optimise efficacy. For now, let the shorter shave their fun

[trotterstrading] 08/4/2019 08:40

Huge bounce coming here, in fact I'm predicting a BLUE finish. I spoke with Cath at length at UKI, these results are VERY GOOD! Nailed on commercial deal with global corporate - all will be explained later today. I was expecting this market reaction and have been adding all morning!

[7ilas] 08/4/2019 08:37

Nailed it. If it improves already healthy skin, It bodes well for damaged skin.

[riskybusiness1] 08/4/2019 08:35

It's not groundbreaking but it was never going to be groundbreaking on healthy skin that will come later on diseased skin. To show improvement in healthy skin is really good news no matter how market has taken it. I think it's the curse of Cath O'Neil RNS she basically gets the regulator to write the RNS. That's what it looks like anyway.

[siennadelekat21] 08/4/2019 08:23

Gotta be a great (and cheap) buying opportunity for people that can read between the lines.Sienna

[jamesrs1] 08/4/2019 08:19

No adverse side-effects shown in all volunteers. Shows a solid platform to Adjust possible formulation.